Results 11 to 20 of about 77,790 (265)

Cannabis use and cannabis use disorder

open access: yesNature Reviews Disease Primers, 2021
Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects ~10% of the 193 million cannabis users worldwide. The individual and public health burdens are less than those of other forms of drug use, but CUD accounts for a substantial proportion of persons seeking treatment for drug use disorders owing to the high global ...
Jason P. Connor   +5 more
openaire   +7 more sources

Cannabis prices and dynamics of cannabis use [PDF]

open access: yesJournal of Health Economics, 2005
This paper uses duration models and self-reported cannabis histories from young Australians to study the dynamics of cannabis use. We find that low cannabis prices are associated with early initiation into cannabis use. While the decision to quit does not appear to be directly influenced by price, we find that the younger an individual is when they ...
van Ours, JC, Williams, J
openaire   +8 more sources

Cannabis and schizophrenia [PDF]

open access: yesCochrane Database of Systematic Reviews, 2014
Schizophrenia is a mental illness causing disordered beliefs, ideas and sensations. Many people with schizophrenia smoke cannabis, and it is unclear why a large proportion do so and if the effects are harmful or beneficial. It is also unclear what the best method is to allow people with schizophrenia to alter their cannabis intake.To assess the effects
Jonathan A, Pushpa-Rajah   +6 more
openaire   +4 more sources

Cannabis use and support for cannabis legalization [PDF]

open access: yesEmpirical Economics, 2014
We investigate the determinants of the support for cannabis legalization finding a causal effect of personal experience with cannabis use. Current and past cannabis users are more in favor of legalization. We relate this finding to self-interest and inside information about potential dangers of cannabis.
Palali, Ali, van Ours, Jan C
openaire   +7 more sources

Cannabis and Driving [PDF]

open access: yesFrontiers in Psychiatry, 2021
As more states in the U.S legalize recreational and medicinal cannabis, rates of driving under the influence of this drug are increasing significantly. Aspects of this emerging public health issue potentially pit science against public policy. The authors believe that the legal cart is currently significantly ahead of the scientific horse.
Godfrey D. Pearlson   +5 more
openaire   +3 more sources

Cannabis [PDF]

open access: yesArchives of Disease in Childhood, 1997
Abstract A robust but otherwise undistinguished weed now labelled Cannabis sativa has provided the world with one of its most remarkable drugs. The psychoactive and medicinal properties of cannabis have been recognized for thousands of years, and it was probably humankind’s first non-food crop.
openaire   +2 more sources

The Immunopathology of COVID-19 and the Cannabis Paradigm

open access: yesFrontiers in Immunology, 2021
Coronavirus disease-19 caused by the novel RNA betacoronavirus SARS-CoV2 has first emerged in Wuhan, China in December 2019, and since then developed into a worldwide pandemic with >99 million people afflicted and >2.1 million fatal outcomes as of ...
Nicole Paland   +8 more
doaj   +1 more source

Three Decades of Cannabis Research: What are the Obstacles?

open access: yesRambam Maimonides Medical Journal, 2022
During the past few years, thousands of articles have been published concerning medical cannabis useage. Unfortunately, most publications are case studies or small and poorly designed research projects. In attempting to understand the reasons behind this
Michael Dor
doaj   +1 more source

High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs

open access: yesFrontiers in Immunology, 2022
Cytokine storm refers to the dysregulated production of inflammatory mediators leading to hyperinflammation. They are often detrimental, and worsen the severity of COVID-19 and other infectious or inflammatory diseases.
Miran Aswad   +8 more
doaj   +1 more source

Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules

open access: yesFrontiers in Pharmacology, 2022
Cannabis sativa contains more than 120 cannabinoids and 400 terpene compounds (i.e., phytomolecules) present in varying amounts. Cannabis is increasingly available for legal medicinal and non-medicinal use globally, and with increased access comes the ...
Ayat Zagzoog   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy